Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tamoxifen methiodide

Drug Profile

Tamoxifen methiodide

Alternative Names: PRS 311.003; Tamoxifen methyl iodide; TMI

Latest Information Update: 04 Dec 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharmos Corporation; Weizmann Institute of Science
  • Class Antineoplastics; Phenyl ethers; Small molecules; Stilbenes; Trimethyl ammonium compounds
  • Mechanism of Action Selective estrogen receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 26 Nov 2002 No development reported - Preclinical for Cancer in Israel (unspecified route)
  • 26 Nov 2002 No development reported - Preclinical for Cancer in USA (unspecified route)
  • 25 Feb 2000 Pharmos has been granted a new patent for permanently charged steroid hormone derivatives in the USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top